Navana Pharmaceuticals (DHA:NAVANAPHAR) Change In Inventory : BDT0.00 Mil (TTM As of . 20)

View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals Change In Inventory?

Navana Pharmaceuticals's change in inventory for the quarter that ended in . 20 was BDT0.00 Mil. It means Navana Pharmaceuticals's inventory stayed the same from . 20 to . 20 .

Navana Pharmaceuticals's change in inventory for the fiscal year that ended in . 20 was BDT0.00 Mil. It means Navana Pharmaceuticals's inventory stayed the same from . 20 to . 20 .

Navana Pharmaceuticals's Total Inventories for the quarter that ended in . 20 was BDT0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Navana Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Navana Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals Change In Inventory Chart

Navana Pharmaceuticals Annual Data

Trend

Change In Inventory

Navana Pharmaceuticals Semi-Annual Data

Change In Inventory

Navana Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Navana Pharmaceuticals (DHA:NAVANAPHAR) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Navana Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/		*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Navana Pharmaceuticals's Inventory Turnover for the quarter that ended in . 20 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=		/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Navana Pharmaceuticals's Inventory to Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/
	=	N/A

Navana Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Navana Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Navana Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213

Website

https://www.navanapharma.com

Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines